Tecan Group (TECN) Panoramica del titolo
Tecan Group AG fornisce strumenti e soluzioni di laboratorio nel settore biofarmaceutico, forense e della diagnostica clinica in Europa, Nord America, Asia e a livello internazionale. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 5/6 |
| Crescita futura | 3/6 |
| Prestazioni passate | 0/6 |
| Salute finanziaria | 5/6 |
| Dividendi | 4/6 |
TECN Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di Tecan Group AG
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | CHF 149.10 |
| Massimo di 52 settimane | CHF 177.50 |
| Minimo di 52 settimane | CHF 110.60 |
| Beta | 1.01 |
| Variazione di 1 mese | 20.05% |
| Variazione a 3 mesi | 11.60% |
| Variazione di 1 anno | -12.09% |
| Variazione a 3 anni | -58.28% |
| Variazione a 5 anni | -66.24% |
| Variazione dall'IPO | 217.91% |
Notizie e aggiornamenti recenti
Aggiornamento della narrazione • May 02
TECN: Updated Discount Assumptions Will Shape Perceived Upside Potential
Tecan Group's analyst price target has been reduced by CHF 1 to CHF 136, as analysts factor in updated discount rate and valuation assumptions, along with modest adjustments to revenue growth, profit margin and future P/E inputs. Analyst Commentary Recent research points to a more cautious tone around Tecan Group, with reduced price targets reflecting reassessed assumptions on growth, profitability and valuation multiples.
Aggiornamento della narrazione • Apr 18
TECN: AI Lab Collaboration And Execution Discipline Will Support Future Earnings
The analyst price target for Tecan Group has shifted slightly to around CHF 167, with recent CHF 1 and CHF 17 target reductions from different firms. These moves have led analysts to fine tune assumptions on discount rate, revenue growth, profit margin and future P/E, without changing the overall valuation picture in a major way.Aggiornamento della narrazione • Apr 03
TECN: Mixed Research Views And 2026 Guidance Shape Forward Expectations
Analysts have trimmed their average price target on Tecan Group to CHF 205, a CHF 17 reduction from recent levels. This reflects updated views on discount rates, revenue growth, profit margins and future P/E assumptions following mixed target moves across the Street.Recent updates
Aggiornamento della narrazione • May 02
TECN: Updated Discount Assumptions Will Shape Perceived Upside Potential
Tecan Group's analyst price target has been reduced by CHF 1 to CHF 136, as analysts factor in updated discount rate and valuation assumptions, along with modest adjustments to revenue growth, profit margin and future P/E inputs. Analyst Commentary Recent research points to a more cautious tone around Tecan Group, with reduced price targets reflecting reassessed assumptions on growth, profitability and valuation multiples.Aggiornamento della narrazione • Apr 18
TECN: AI Lab Collaboration And Execution Discipline Will Support Future Earnings
The analyst price target for Tecan Group has shifted slightly to around CHF 167, with recent CHF 1 and CHF 17 target reductions from different firms. These moves have led analysts to fine tune assumptions on discount rate, revenue growth, profit margin and future P/E, without changing the overall valuation picture in a major way.Aggiornamento della narrazione • Apr 03
TECN: Mixed Research Views And 2026 Guidance Shape Forward Expectations
Analysts have trimmed their average price target on Tecan Group to CHF 205, a CHF 17 reduction from recent levels. This reflects updated views on discount rates, revenue growth, profit margins and future P/E assumptions following mixed target moves across the Street.Aggiornamento della narrazione • Mar 20
TECN: AI Lab Collaboration Will Support Forward Efficiency Gains And Earnings
The updated analyst price target for Tecan Group moves to CHF 166.50 from CHF 192.57, reflecting mixed Street views as some analysts trim targets while others highlight support from higher assumed revenue growth and a slightly lower future P/E multiple. Analyst Commentary Recent Street research on Tecan Group points to a split view, with some analysts trimming price targets and others turning more constructive on the shares.Aggiornamento della narrazione • Mar 05
TECN: Mixed Research Views And Investor Day Outlook Shape Future Expectations
Analysts have trimmed their price target for Tecan Group to CHF 137.00 from CHF 165.20, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E. Recent research also includes both a Morgan Stanley target cut and target and rating adjustments from other firms.
Aggiornamento della narrazione • Feb 19
TECN: Recent Upgrade And CHF 205 Goal Will Support Higher Long Term P/E
Analysts have nudged their price targets on Tecan Group slightly lower, with moves such as Morgan Stanley trimming its target by CHF 5 and others, including Bernstein and Berenberg, adjusting their outlooks. These revisions have led to only marginal changes in modeled fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.Aggiornamento della narrazione • Feb 05
TECN: CFO Transition And Execution Will Support Higher Long Term P/E Potential
Analysts have nudged their price expectations for Tecan Group slightly higher, with the updated fair value estimate moving from CHF 334.71 to about CHF 335.08. This reflects small model adjustments to growth, margins and long term P/E assumptions after recent mixed target moves from banks that both lowered and raised their CHF based price targets.Aggiornamento della narrazione • Jan 22
TECN: Execution And CFO Transition Will Support Upgraded Outlook And Medium Term Upside
Narrative Update The analyst price target for Tecan Group has been revised to CHF 205 from CHF 200. Analysts cite updated assumptions on growth, profitability and a higher future P/E multiple as the main factors behind this change.Aggiornamento della narrazione • Jan 08
TECN: Efficiency Gains And Gradual Market Recovery Will Support Forward Earnings
Analysts have trimmed their price target on Tecan Group to about CHF 193 from around CHF 202, reflecting slightly lower fair value estimates, supported by recent target reductions such as the move to CHF 170 cited in Street research. Analyst Commentary Recent Street commentary around Tecan Group points to a more cautious stance, with price targets being reset closer to CHF 170, which sits below the trimmed average around CHF 193.Articolo di analisi • Dec 23
Does Tecan Group (VTX:TECN) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Aggiornamento della narrazione • Dec 14
TECN: Medium Term Execution And CFO Transition Will Support Future Upside Potential
Analysts have lowered their price target on Tecan Group to CHF 170 from CHF 177, reflecting a slightly higher discount rate despite modestly improved revenue growth and profit margin expectations. Analyst Commentary Bullish analysts acknowledge the modest reduction in the price target but view the revised CHF 170 level as still supportive of upside potential from current trading levels, given improving fundamentals and execution.Aggiornamento della narrazione • Nov 30
TECN: Efficiency Gains And Market Recovery Will Drive Forward Earnings Improvements
Analysts have reduced their price target for Tecan Group from CHF 177 to CHF 170. They cited revised market assumptions and modest adjustments to key financial forecasts as reasons for this change.Aggiornamento della narrazione • Nov 16
TECN: Automation Demand And Partnerships Will Drive Earnings Recovery After 2026
Tecan Group: Analyst Price Target Reduced on Updated Outlook Analysts have lowered their fair value estimate for Tecan Group from CHF 205.98 to CHF 202.48. They cited slightly higher discount rates and tempered expectations for revenue growth and profit margins as reasons for the change.Articolo di analisi • Nov 06
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 90% Above Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF261 Tecan Group's CHF138...Aggiornamento della narrazione • Nov 01
TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value
The analyst price target for Tecan Group has been revised downward from CHF 177 to CHF 170. Analysts cite slightly softer revenue growth expectations and a modest increase in the discount rate in their updated assessments.Articolo di analisi • Oct 22
Should You Investigate Tecan Group AG (VTX:TECN) At CHF150?
Tecan Group AG ( VTX:TECN ), is not the largest company out there, but it saw significant share price movement during...Aggiornamento della narrazione • Oct 18
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Tecan Group's updated analyst fair value price target has been revised downward from CHF 215.73 to CHF 207.23. This change reflects cautious analyst views amid slower revenue growth and tightened profit margin expectations.Aggiornamento della narrazione • Oct 04
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Analysts have adjusted their price target for Tecan Group downward, reducing the fair value estimate from CHF 220.47 to CHF 215.73. This change is due to a slight increase in the discount rate, although forecasts for revenue growth and profit margins have improved.Aggiornamento della narrazione • Sep 05
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Analysts have lowered their outlook for Tecan Group due to concerns over near-term margin pressure, cautious end-market demand, and delayed recovery in key segments, though the consensus price target remained unchanged at CHF220.47. Analyst Commentary Cautious sentiment due to anticipation of "soft" first-half financial results impacting near-term performance.Articolo di analisi • Sep 04
Tecan Group (VTX:TECN) Has A Pretty Healthy Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • Aug 20
Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)
SWX:TECN 1 Year Share Price vs Fair Value Explore Tecan Group's Fair Values from the Community and select yours The...Articolo di analisi • Aug 08
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 81% Above Its Share Price
Key Insights Tecan Group's estimated fair value is CHF281 based on 2 Stage Free Cash Flow to Equity Current share price...Articolo di analisi • Jul 21
Why We're Not Concerned About Tecan Group AG's (VTX:TECN) Share Price
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...Articolo di analisi • May 28
At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?
While Tecan Group AG ( VTX:TECN ) might not have the largest market cap around , it saw a significant share price rise...Articolo di analisi • Apr 24
Is Tecan Group AG (VTX:TECN) Trading At A 26% Discount?
Key Insights Tecan Group's estimated fair value is CHF199 based on 2 Stage Free Cash Flow to Equity Tecan Group is...Articolo di analisi • Apr 08
Tecan Group AG (VTX:TECN) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
To the annoyance of some shareholders, Tecan Group AG ( VTX:TECN ) shares are down a considerable 25% in the last...Articolo di analisi • Apr 04
Here's Why Shareholders Should Examine Tecan Group AG's (VTX:TECN) CEO Compensation Package More Closely
Key Insights Tecan Group will host its Annual General Meeting on 10th of April Total pay for CEO Achim von Leoprechting...Articolo di analisi • Apr 01
Is Tecan Group (VTX:TECN) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Nuova narrazione • Mar 16
Expansion Into South Korea And FDA Approval To Support Future High-Value Medical Device Production
Expansion into South Korea and FDA approval in Malaysia bolster Tecan's production and revenue growth potential in medical devices.Articolo di analisi • Jan 12
Tecan Group AG's (VTX:TECN) Share Price Could Signal Some Risk
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...Articolo di analisi • Dec 21
A Look At The Fair Value Of Tecan Group AG (VTX:TECN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF231 With CHF198 share...Articolo di analisi • Oct 09
Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 33.7x Tecan Group AG ( VTX:TECN ) may be sending very bearish signals at...Articolo di analisi • Sep 21
These 4 Measures Indicate That Tecan Group (VTX:TECN) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Articolo di analisi • Aug 16
Earnings Report: Tecan Group AG Missed Revenue Estimates By 8.8%
It's been a sad week for Tecan Group AG ( VTX:TECN ), who've watched their investment drop 13% to CHF280 in the week...Articolo di analisi • Jun 14
Is Tecan Group (VTX:TECN) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Articolo di analisi • Apr 20
Calculating The Fair Value Of Tecan Group AG (VTX:TECN)
Key Insights Tecan Group's estimated fair value is CHF409 based on 2 Stage Free Cash Flow to Equity Current share price...Articolo di analisi • Apr 02
Tecan Group AG's (VTX:TECN) Business Is Yet to Catch Up With Its Share Price
With a price-to-earnings (or "P/E") ratio of 36.2x Tecan Group AG ( VTX:TECN ) may be sending very bearish signals at...Rendimenti per gli azionisti
| TECN | CH Life Sciences | CH Mercato | |
|---|---|---|---|
| 7D | 4.5% | 1.5% | 1.2% |
| 1Y | -12.1% | -7.7% | 8.1% |
Ritorno vs Industria: TECN ha avuto una performance inferiore rispetto al Swiss Life Sciences che ha registrato un rendimento -7.7 % nell'ultimo anno.
Rendimento vs Mercato: TECN ha avuto una performance inferiore al mercato Swiss che ha registrato un rendimento 8.1 % nell'ultimo anno.
Volatilità dei prezzi
| TECN volatility | |
|---|---|
| TECN Average Weekly Movement | 6.0% |
| Life Sciences Industry Average Movement | 5.9% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in CH Market | 8.2% |
| 10% least volatile stocks in CH Market | 2.4% |
Prezzo delle azioni stabile: TECN non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato Swiss.
Volatilità nel tempo: La volatilità settimanale ( 6% ) di TECN è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1980 | 3,166 | Monica Manotas | www.tecan.com |
Tecan Group AG fornisce strumenti e soluzioni di laboratorio nel settore biofarmaceutico, forense e della diagnostica clinica in Europa, Nord America, Asia e a livello internazionale. Opera in due segmenti, Life Sciences Business e Partnering Business. L'azienda offre sistemi di manipolazione e automazione dei liquidi, lettori e lavatori di micropiastre, software, materiali di consumo, reagenti NGS, immunodosaggi e anticorpi e Tecan Labwerx, una soluzione di automazione end-to-end.
Tecan Group AG Riepilogo dei fondamenti
| TECN statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | CHF 1.87b |
| Utili (TTM) | -CHF 110.65m |
| Ricavi(TTM) | CHF 882.48m |
2.1x
Rapporto P/S-16.9x
Rapporto P/ETECN è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| TECN Conto economico (TTM) | |
|---|---|
| Ricavi | CHF 882.48m |
| Costo del fatturato | CHF 571.64m |
| Profitto lordo | CHF 310.84m |
| Altre spese | CHF 421.49m |
| Utili | -CHF 110.65m |
Ultimi utili riportati
Dec 31, 2025
Prossima data di guadagno
Aug 11, 2026
| Utile per azione (EPS) | -8.83 |
| Margine lordo | 35.22% |
| Margine di profitto netto | -12.54% |
| Rapporto debito/patrimonio netto | 13.1% |
Come si è comportato TECN nel lungo periodo?
Vedi performance storica e confrontoDividendi
2.0%
Rendimento attuale del dividendo-34%
Rapporto di remunerazioneAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/26 11:49 |
| Prezzo dell'azione a fine giornata | 2026/05/26 00:00 |
| Utili | 2025/12/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Tecan Group AG è coperta da 18 analisti. 8 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Harry Gillis | Berenberg |
| Delphine Le Louet | Bernstein |
| Susannah Ludwig | Bernstein |